Business Context and Reporting Period
Company: Albemarle Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2006
Business Overview: Albemarle is a global developer, manufacturer, and marketer of highly engineered specialty chemicals, operating through three primary segments: Polymer Additives, Catalysts, and Fine Chemicals.
Key Financial Metrics
All figures in millions unless otherwise noted.
| Metric | Three Months Ended June 30, 2006 |
Six Months Ended June 30, 2006 |
|---|---|---|
| Net Sales | $568.8 | $1,176.2 |
| Gross Profit | $131.4 | $253.8 |
| Gross Margin | 23.1% | 21.6% |
| Operating Profit | $58.0 | $111.1 |
| Net Income | $43.3 | $77.7 |
| Diluted EPS | $0.89 | $1.60 |
| Cash from Operations | N/A | $131.8 |
| Cash and Equivalents | $99.0 (Balance Sheet) | $99.0 (Balance Sheet) |
| Total Debt | $850.4 (Current + Long-term) | $850.4 (Current + Long-term) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 13% ($66.0M) for the quarter and 16% ($163.5M) for the six-month period compared to 2005. Growth was driven by improved pricing (up 9% Q/Q, 12% YTD) and volume increases (up 5% Q/Q, 7% YTD).
- Profitability: Net income rose 35% for the quarter and 38% for the six-month period. This was fueled by higher sales, improved gross margins (23.1% vs. 20.9% in Q2), and a significantly lower effective tax rate (25.3% vs. 38.8% in Q2).
- Segment Performance:
- Polymer Additives: Sales up 12% (Q2) and 12% (YTD); Income up 38% (Q2) and 39% (YTD) due to pricing and volume gains.
- Catalysts: Sales up 32% (Q2) and 34% (YTD); Income up 21% (Q2) and 11% (YTD) driven by refinery catalyst demand.
- Fine Chemicals: Sales down 3% (Q2) but up 2% (YTD); Income declined 7% (Q2) and 11% (YTD) due to volume reductions and higher costs, partially offset by pricing.
- Working Capital: Net current assets increased $61.7M to $513.5M, primarily due to higher cash and accounts receivable balances.
Guidance, Outlook, and Risks
- Outlook: Management expects stable volumes in Polymer Additives with pricing initiatives to offset rising raw material costs. The Catalysts segment remains "sold out" with strong volumes expected in Q3. Fine Chemicals is expected to continue a turnaround in the second half, potentially trading volume for margin.
- Capital Expenditures: Expected to be $100M–$110M for 2006, focused on capacity expansion. Remaining 2006 spend is estimated at $50M–$60M.
- Significant Contingency (Thann, France): The company is consulting with the Works Council regarding a potential shutdown of its Thann, France facility. Upon completion, Albemarle expects to take a pre-tax charge in the range of $100 million, exclusive of environmental remediation costs. The company believes it is entitled to indemnification from Aventis for these liabilities but notes no assurance of prevailing.
- Legal Proceedings: An arbitration regarding environmental liabilities at the Thann facility is ongoing. A partial award confirmed the validity of the indemnity, but the exact liability amount is yet to be determined by an expert.
- Accounting Changes: The company adopted SFAS 123R (Share-Based Payment) effective January 1, 2006, resulting in additional compensation expense.
Investor Verification Checklist
- Thann Facility Charge: Verify the timeline and final magnitude of the expected $100M pre-tax charge related to the potential shutdown of the Thann, France facility.
- Indemnification Status: Monitor the progress of the arbitration against Aventis regarding environmental liabilities at the Thann site to assess the likelihood of recovering the shutdown and remediation costs.
- Raw Material Costs: Assess the company's ability to pass through continued increases in raw material and energy costs to maintain gross margins.
- Debt Covenants: Confirm continued compliance with financial covenants, specifically the consolidated fixed charge coverage ratio (must be ≥ 1.25:1) and debt-to-capitalization ratio (must be ≤ 60%).
- Foreign Exchange Impact: Review the impact of currency fluctuations, particularly the Euro, on reported earnings and cash flows given significant international operations.